Personalized Therapy for Multiple Myeloma '17
目次
Risk stratification in newly diagnosed smoldering multiple myeloma.- Risk stratification in newly diagnosed transplant eligible multiple myeloma.- Risk stratification in newly diagnosed transplant ineligible multiple myeloma.- Treatment of translocation 4;14 and deletion 17 p MM.- Treatment of patients in first/second relapse.- Treatment of patients in third relapse and beyond including double refractory disease.- Treatment of primary and secondary plasma cell leukemia.- Practical considerations for bone health in multiple myeloma.- Personalizing MM treatment: gaps in knowledge that we need to overcome.
カート
カートに商品は入っていません。